Skip to main content

BioScience Health Innovations, Inc.

corporate_fare Company Profile

BioScience Health Innovations, Inc.

BHIC·OTC·Technology·CIK 0001784440

BioScience Health Innovations, Inc. operates as a health and wellness innovation company focused on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. The company offers nutritional supplements, peptides, and bioactive compounds, primarily utilizing its core technology, the Mineral Oxide Delivery System. In addition to these products, BioScience Health Innovations, Inc. provides Oracle NetSuite, an accounting and financial reporting system. The company's service offerings include testosterone and hormonal optimization, NAD+ and cellular health, and platform licensing and peptide delivery. Products are sold through the Amazon platform and direct-to-consumer channels. The company was formerly known as Nowtransit Inc and officially changed its name to BioScience Health Innovations, Inc. in February 2025. BioScience Health Innovations, Inc. is based in Bluffdale, Utah.

BioScience Health Innovations, Inc. (OTC:BHIC) is a publicly traded company in the Technology sector. Wiseek monitors BHIC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • BioScience Health Innovations Amends Offering, Raises Price to $4.50/Share for $5.0M Capital Raise
  • BioScience Health Innovations Reports Q1 Loss, Negative Operating Cash Flow, and Material Internal Control Weaknesses
  • BioScience Health Innovations Reports Strong 2025 Growth Amidst Critical Internal Control Weaknesses

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.69M
Net Income
$642.09K
Diluted EPS
$0.06
Op. Cash Flow
$172.18K
Gross Profit
$3.24M
Operating Income
$719.05K
Cash & Equivalents
$661.92K
Debt / Equity
0.00×
Net Margin
11.3%
Shares Outstanding
10.98M sh
Source: 10-K · filed 2026-03-30 · accession 0001185185-26-001133

Dilution Risk

Low risk

Filing-implied dilution signals for BHIC, detected from its recent SEC filings · based on capital-structure filings through 2026-07-06.

Offering Price Increased Significantly · Substantial Capital Raise

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with B →
$4
52-week range · as of 2026-07-06 $0.5204 – $72
Market cap
$45.66M
Volume
1.1K (0.1× avg)
3-mo avg 7.4K
Live data · 2026-07-29 11:20 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed BHIC - Latest Insights

BHIC
Jul 06, 2026, 5:10 PM EDT
Filing Type: 1-A POS
Importance Score:
8
BioScience Health Innovations Amends Offering, Raises Price to $4.50/Share for $5.0M Capital Raise
Price at Filing: $4.50
Real-time Price: $4.00 info
Change: -$0.500 (-11%) info
Market Cap: $45.665M info
Sentiment: Positive
View Wiseek Article
BHIC
May 11, 2026, 9:59 AM EDT
Filing Type: 10-Q
Importance Score:
8
BioScience Health Innovations Reports Q1 Loss, Negative Operating Cash Flow, and Material Internal Control Weaknesses
Price at Filing: $4.71
Real-time Price: $4.00 info
Change: -$0.7053 (-15%) info
Market Cap: $45.665M info
Sentiment: Negative
View Wiseek Article
BHIC
Mar 30, 2026, 10:48 AM EDT
Filing Type: 10-K
Importance Score:
8
BioScience Health Innovations Reports Strong 2025 Growth Amidst Critical Internal Control Weaknesses
Price at Filing: $2.15
Real-time Price: $4.00 info
Change: +$1.85 (+86%) info
Market Cap: $45.665M info
Sentiment: Negative
View Wiseek Article